Adamis Pharmaceuticals Corporation (ADMP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.46+0.69 (+24.91%)
At close: 4:00 PM EDT

3.71 0.24 (6.92%)
After hours: 5:31 PM EDT

People also watch:
TNXPACRXDNAIALIMAKAO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.89
Prev Close2.77
Bid3.73 x 100
Ask3.73 x 200
Day's Range2.83 - 3.57
52wk Range2.50 - 10.98
1y Target EstN/A
Market Cap72.27M
P/E Ratio (ttm)-2.55
Beta0.63
Volume14,956,435
Avg Vol (3m)422,315
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com6 hours ago

    Here's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Soaring Today

    Adamis Pharmaceuticals (ADMP) could benefit from rival Mylan's (MYL) high price of EpiPens as its own product is reportedly close to approval.

  • Barrons.com10 hours ago

    [$$] Mylan's EpiPen Fallout Benefits Adamis

    Adamis Pharmaceuticals (ADMP:Nasdaq) By Maxim Group ($2.99, Aug. 24, 2016) We believe Adamis Pharmaceuticals’ pre-filled syringe is close to becoming an approved product. Mylan’s (MYL) EpiPen was mentioned in the press as an example of “price gouging,” highlighting the significant price increase of the product. Adamis’ (ADMP) pre-filled syringe (PFS) could be the solution.

  • TheStreet.comyesterday

    Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem

    The pharmaceutical company announced that it will increase its patient assistance program in hopes of quelling a growing backlash over its drug pricing.